Table 2.

Patient Characteristics

	All patients enrolled in AMS during study period (n = 5871)	Patients with co-prescribing, pre-intervention (n = 1553)	Patients with co-prescribing, post-intervention (n = 1709)	P Value*
Sex				0.46
Female	46.4 %	47.5 %	46.8 %
Male	53.6 %	52.5 %	53.2 %
Age				0.01
18-49 years	8.6 %	5.5 %	6.5 %
50-59 years	12.1 %	10.9 %	10.5 %
60-69 years	20.7 %	18.5 %	21.5 %
70-79 years	26.0 %	30.5 %	27.7 %
80+ years	32.4 %	34.5 %	33.8 %
Race/Ethnicity				0.16
White	80.2 %	84.8 %	83.6 %
Black	8.4 %	7.9 %	7.5 %
Other	6.6 %	5.7 %	6.7 %
Missing	4.8 %	1.5 %	2.2 %
Indication for Anticoagulation†
Atrial Fibrillation	48.5 %	52.5 %	56.2 %	0.02
DVT	22.6 %	12.6 %	17.3 %	<0.001
PE	20.3 %	9.8 %	15.2 %	<0.001
Atrial Flutter	12.3 %	3.2 %	14.3 %	<0.001
DVT/PE Prophylaxis	6.6 %	1.5 %	3.0 %	0.001
Stroke	3.5 %	3.9 %	4.0 %	0.90
Prosthetic valve	3.5 %	4.5 %	4.5 %	0.85

^*P values reflect the comparison of patients with co-prescribing pre-intervention to patients with co-prescribing post-intervention

^†Indications for anticoagulation: Totals may exceed 100 % because patients may have more than one indication for anticoagulation

DVT = deep vein thrombosis; PE = pulmonary embolism